VANCOUVER, B.C.–(BUSINESS WIRE)–Alpha Cognition Inc. (TSX-V: ACOG)(OTCQB:ACOGF)(Alpha Cognition, or the Company), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating…
